This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
November 9–11, 2026
KoelnmesseCologne, Germany

Jun-Eui Park
Head of BD & Strategy at Mustbio
Presenter

Profile

Dr. Juneui Park is an accomplished scientist and business development leader with over 20 years of experience in oncology and immuno-oncology drug research and development. A licensed pharmacist by training, she began her career with academic research at Memorial Sloan-Kettering Cancer Center following a Ph.D. from the University at Buffalo (Roswell Park Cancer Institute). Prior to her current role at MustBio, she held leadership positions at Autotelic Bio, Genexine, and JW CreaGene, leading programs in cell therapy, protein therapeutics, and antisense oligonucleotide (ASO) platforms across oncology and immuno-oncology indications. At MustBio, she currently leads strategic partnerships and global initiatives focused on multi-specific antibody therapeutics and immunocytokines, advancing next-generation immuno-oncology approaches.